Haemonetics' GAAP net income for fiscal year 2022 was $43.375 million, down 45.4% from $79.469 million in the prior year. Revenue increased 14.1% to $993.196 million from $870.463 million a year earlier.
Haemonetics' GAAP net income for fiscal year 2022 was $43.375 million, down 45.4% from $79.469 million in the prior year. Revenue increased 14.1% to $993.196 million from $870.463 million a year earlier. 
English (US) 